BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 932 filers reported holding BAXTER INTL INC in Q1 2023. The put-call ratio across all filers is 0.56 and the average weighting 0.1%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $13,806,640 | -39.1% | 303,043 | -45.8% | 0.00% | -25.0% |
| Q1 2023 | $22,688,858 | -98.8% | 559,390 | -98.5% | 0.00% | -98.9% |
| Q4 2022 | $1,840,232,756 | -42.1% | 36,104,233 | -38.8% | 0.37% | -45.5% |
| Q3 2022 | $3,177,342,000 | -20.1% | 58,992,617 | -4.7% | 0.68% | -15.5% |
| Q2 2022 | $3,975,015,000 | -7.7% | 61,887,205 | +11.4% | 0.80% | +8.5% |
| Q1 2022 | $4,308,894,000 | +1.1% | 55,569,944 | +11.9% | 0.74% | +8.2% |
| Q4 2021 | $4,262,029,000 | +4.8% | 49,650,853 | -1.8% | 0.68% | -1.4% |
| Q3 2021 | $4,067,337,000 | -1.6% | 50,569,880 | -1.5% | 0.69% | +0.6% |
| Q2 2021 | $4,131,827,000 | -4.1% | 51,327,035 | +0.4% | 0.69% | -9.4% |
| Q1 2021 | $4,310,300,000 | +29.9% | 51,106,228 | +23.5% | 0.76% | +24.2% |
| Q4 2020 | $3,319,187,000 | +43.6% | 41,365,746 | +43.9% | 0.61% | +27.8% |
| Q3 2020 | $2,311,674,000 | -6.9% | 28,745,014 | -0.4% | 0.48% | -13.6% |
| Q2 2020 | $2,483,778,000 | +2.2% | 28,847,584 | -3.6% | 0.55% | -14.0% |
| Q1 2020 | $2,429,202,000 | -7.0% | 29,919,983 | -4.2% | 0.64% | +17.6% |
| Q4 2019 | $2,611,279,000 | -2.6% | 31,227,927 | +1.9% | 0.55% | -9.6% |
| Q3 2019 | $2,681,462,000 | -0.3% | 30,655,786 | -6.7% | 0.60% | +1.5% |
| Q2 2019 | $2,690,724,000 | +2.0% | 32,853,752 | +1.3% | 0.60% | -0.2% |
| Q1 2019 | $2,637,699,000 | +24.3% | 32,440,009 | +0.6% | 0.60% | +12.4% |
| Q4 2018 | $2,121,596,000 | -0.4% | 32,233,295 | +16.7% | 0.53% | +18.5% |
| Q3 2018 | $2,129,312,000 | +48.1% | 27,621,127 | +41.8% | 0.45% | +40.0% |
| Q2 2018 | $1,437,990,000 | +28.7% | 19,474,387 | +13.4% | 0.32% | +26.5% |
| Q1 2018 | $1,117,380,000 | +0.8% | 17,179,898 | +0.1% | 0.25% | +3.3% |
| Q4 2017 | $1,108,884,000 | +18.8% | 17,154,757 | +15.3% | 0.24% | +14.5% |
| Q3 2017 | $933,349,000 | +36.6% | 14,874,084 | +31.8% | 0.21% | +32.9% |
| Q2 2017 | $683,158,000 | +51.8% | 11,284,420 | +30.0% | 0.16% | +49.1% |
| Q1 2017 | $450,001,000 | +8.7% | 8,677,237 | -7.1% | 0.11% | +3.8% |
| Q4 2016 | $413,933,000 | -29.5% | 9,335,451 | -24.3% | 0.10% | -29.3% |
| Q3 2016 | $586,968,000 | -42.5% | 12,331,280 | -45.4% | 0.15% | -44.3% |
| Q2 2016 | $1,020,660,000 | -28.6% | 22,570,977 | -35.1% | 0.26% | -29.8% |
| Q1 2016 | $1,428,601,000 | +13.7% | 34,776,050 | +5.6% | 0.38% | +14.3% |
| Q4 2015 | $1,256,261,000 | +24.7% | 32,929,474 | +7.4% | 0.33% | +17.1% |
| Q3 2015 | $1,007,174,000 | +91.5% | 30,659,767 | +307.7% | 0.28% | +106.6% |
| Q2 2015 | $525,879,000 | +52.2% | 7,520,076 | +49.1% | 0.14% | +52.8% |
| Q1 2015 | $345,518,000 | -7.0% | 5,044,059 | -0.5% | 0.09% | -9.2% |
| Q4 2014 | $371,416,000 | +2.3% | 5,067,759 | +0.2% | 0.10% | -2.0% |
| Q3 2014 | $363,072,000 | -0.5% | 5,058,828 | +0.3% | 0.10% | +2.0% |
| Q2 2014 | $364,789,000 | -11.5% | 5,045,482 | -10.0% | 0.10% | -14.0% |
| Q1 2014 | $412,329,000 | -26.3% | 5,603,831 | -30.3% | 0.11% | -29.2% |
| Q4 2013 | $559,418,000 | -4.5% | 8,043,389 | -9.8% | 0.16% | -12.0% |
| Q3 2013 | $585,657,000 | +9.3% | 8,915,457 | +15.2% | 0.18% | +4.6% |
| Q2 2013 | $535,925,000 | – | 7,736,759 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |